Power formulas for mixed effects models with random slope and intercept comparing rate of change across groups

Zhao Yu and Edland Steven D. ()
Additional contact information
Zhao Yu: Division of Biostatistics, School of Public Health & Human Longevity Science, University of California San Diego, 9500 Gilman Dr, 92093-0021 La Jolla, USA
Edland Steven D.: Division of Biostatistics, School of Public Health & Human Longevity Science, University of California San Diego, 9500 Gilman Dr, 92093-0021 La Jolla, USA

The International Journal of Biostatistics, 2022, vol. 18, issue 1, 173-182

Abstract: We have previously derived power calculation formulas for cohort studies and clinical trials using the longitudinal mixed effects model with random slopes and intercepts to compare rate of change across groups [Ard & Edland, Power calculations for clinical trials in Alzheimer’s disease. J Alzheim Dis 2011;21:369–77]. We here generalize these power formulas to accommodate 1) missing data due to study subject attrition common to longitudinal studies, 2) unequal sample size across groups, and 3) unequal variance parameters across groups. We demonstrate how these formulas can be used to power a future study even when the design of available pilot study data (i.e., number and interval between longitudinal observations) does not match the design of the planned future study. We demonstrate how differences in variance parameters across groups, typically overlooked in power calculations, can have a dramatic effect on statistical power. This is especially relevant to clinical trials, where changes over time in the treatment arm reflect background variability in progression observed in the placebo control arm plus variability in response to treatment, meaning that power calculations based only on the placebo arm covariance structure may be anticonservative. These more general power formulas are a useful resource for understanding the relative influence of these multiple factors on the efficiency of cohort studies and clinical trials, and for designing future trials under the random slopes and intercepts model.

Keywords: clinical trial, linear mixed effects model; power, sample size, study subject attrition (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1515/ijb-2020-0107 (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:ijbist:v:18:y:2022:i:1:p:173-182:n:9

Ordering information: This journal article can be ordered from
https://www.degruyter.com/journal/key/ijb/html

DOI: 10.1515/ijb-2020-0107

Access Statistics for this article

The International Journal of Biostatistics is currently edited by Antoine Chambaz, Alan E. Hubbard and Mark J. van der Laan

More articles in The International Journal of Biostatistics from De Gruyter
Bibliographic data for series maintained by Peter Golla ().